tweenvest

ALK-Abelló A/S (CPSE: ALK B)

Health Care · Pharmaceuticals · DK

Dkr248.40

-0.16% today · +7.9% 1Y

Public summary
A free snapshot of ALK-Abelló A/S, with figures as of Nov 15, 2026. The full analysis is in the app.Open in the app

ALK-Abelló A/S (CPSE: ALK B) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $8.14B.

Over the last twelve months the share price has gained 7.9%, trading between 191.80 and 271.40.

Tweenvest scores ALK-Abelló A/S across four factors: quality 81/100, value 51/100, growth 88/100, dividend 17/100. Its strongest factor is growth.

ALK B price history

Nov 21, 2025 · 227.40Weekly closes 195.90 – 270.40Nov 13, 2026 · 248.40

Key figures

Market cap
$8.14B
Revenue (TTM)
$1.04B
P/E
40.73
EPS
6.10
Dividend yield
0.64%
Beta (5Y)
0.74
52-week high
Dkr271.40
52-week low
Dkr191.80
Avg volume (3M)
—
Shares outstanding
221.88M
Employees
—
Next earnings
—
CompanyMarket capPriceDay
Eisai Co., Ltd.TSE: 4523$9.29B¥5,240.00-1.06%
H. Lundbeck A/SCPSE: HLUN B$8.99BDkr62.15+2.22%
Kyowa Kirin Co., Ltd.TSE: 4151$8.39B¥2,552.50-1.05%
Krka, d. d.LJSE: KRKG$8.29B€250.00-0.40%
Glenmark Pharmaceuticals LimitedNSEI: GLENMARK$7.88BRs2,608.50-1.42%
Asymchem Laboratories (Tianjin) Co., Ltd.SZSE: 002821$7.75BCN¥147.41-3.45%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.SHSE: 600196$7.62BCN¥20.71-0.53%
Corcept Therapeutics IncorporatedNasdaqCM: CORT$7.42B$67.79-3.25%

Browse every Pharmaceuticals company →